May 14, 2019 / 05:40PM GMT
Michael Leonidovich Ryskin - BofA Merrill Lynch, Research Division - Associate
So we're ready to get started. So my name is Mike Ryskin. I'm on the Life Science Tools and Diagnostics Team here at Bank of America Merrill Lynch. Thank you for joining us for the conference. I'm here on behalf of the senior analyst on the team, Derik de Bruin. Unfortunately, he couldn't make it today. He had surgery recently; he's unable to travel right now, but he's certainly here in spirit. He would be if he could, and he's following on the webcast where available. On his behalf I'd be remiss if I didn't ask for an [aye-aye] vote. I know it's everyone's favorite time of the season, but he's pretty emphatic that we get the ask out. So the entire tools team and all of Bank of America appreciates your support on that. And so this part of the session is Bio-Rad. We're joined by Norman Schwartz and Ilan Daskal from the company. Thank you for joining us, gentlemen.
Just to start, maybe a high level discussion. If you look at Bio Rad over the last couple years, there's certainly been a lot of change in the company,
Bio Rad Laboratories Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers